Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)371.45
  • Today's Change6.25 / 1.71%
  • Shares traded132.00
  • 1 Year change+85.77%
  • Beta0.6216
Data delayed at least 15 minutes, as of Aug 15 2022 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

McKesson Corporation is a diversified healthcare services provider. The Company is focused on advancing health outcomes for patients everywhere. It operates its business through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter (OTC) pharmaceutical drugs, and other healthcare-related products. Its Prescription Technology Solutions segment serves its biopharma and life sciences partners and patients. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in 11 European countries and Canada.

  • Revenue in USD (TTM)268.45bn
  • Net income in USD1.40bn
  • Incorporated1994
  • Employees58.00k
  • Location
    Mckesson Corp6555 State Highway 161IRVING 75039United StatesUSA
  • Phone+1 (972) 446-4800
  • Fax+1 (302) 636-5454
  • Websitehttps://www.mckesson.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Alnylam Pharmaceuticals, Inc.884.25m-980.72m26.81bn1.67k--159.45--31.49-8.17-8.177.371.450.25861.697.19531,078.10-28.68-32.56-34.85-37.9483.40---110.91-223.643.62-2.990.7938--71.3178.070.6358--3.42--
DuPont de Nemours Inc15.14bn1.23bn29.37bn28.00k25.391.1911.472.012.393.6529.3850.960.33543.965.94540,642.902.87-0.22273.25-0.28934.6331.608.56-1.612.125.060.3016--16.15-19.13172.14-15.09-25.20-26.30
AmerisourceBergen Corp.236.33bn1.84bn29.99bn38.00k16.71134.9111.970.12778.718.711,117.751.084.1814.8012.096,219,
Seagen Inc1.78bn-739.80m32.39bn2.68k--11.04--18.22-4.04-4.049.7015.910.46891.504.35664,625.40-19.51-5.22-22.62-6.0079.5887.67-41.61-9.784.04-211.850.00---27.6330.36-209.91--13.46--
Iqvia Holdings Inc14.14bn1.16bn43.38bn82.00k40.038.3619.553.165.995.9972.9828.680.5847--5.71178,936.704.811.776.062.1434.4234.308.233.64--4.950.70460.0022.1415.28246.2468.0831.30--
McKesson Corporation268.45bn1.40bn50.99bn58.00k38.25--22.940.19259.409.401,782.81-13.924.2912.9213.394,628,380.002.50-0.75489.44-2.384.895.240.5822-0.20140.548343.921.34--10.805.86124.66-26.44-0.97999.71
Moderna Inc23.00bn14.06bn66.95bn2.70k5.313.804.752.9632.8032.8053.7945.881.093.189.768,516,667.0066.6241.17105.9066.7882.29--61.1252.351.71--0.04070.002,199.12179.441,733.33--53.67--
Regeneron Pharmaceuticals Inc14.23bn5.69bn67.82bn10.37k12.813.4011.694.9250.0750.07125.24188.930.58441.022.341,372,184.0023.3625.6427.1329.9984.9788.5139.9739.114.3911.870.1155--89.1427.02129.8655.241.52--
Data as of Aug 15 2022. Currency figures normalised to Mckesson Corp's reporting currency: US Dollar USD

Institutional shareholders

34.64%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202214.62m10.18%
BlackRock Fund Advisorsas of 30 Jun 20226.60m4.60%
SSgA Funds Management, Inc.as of 31 Mar 20226.54m4.56%
Massachusetts Financial Services Co.as of 30 Jun 20224.90m3.41%
JPMorgan Investment Management, Inc.as of 30 Jun 20224.80m3.34%
Berkshire Hathaway, Inc. (Investment Management)as of 31 Mar 20222.92m2.04%
Geode Capital Management LLCas of 30 Jun 20222.52m1.75%
Pzena Investment Management LLCas of 30 Jun 20222.43m1.70%
Putnam Investment Management LLCas of 31 Mar 20222.30m1.60%
Fidelity Management & Research Co. LLCas of 30 Jun 20222.09m1.46%
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.